|
|
| MRD / Regn No. |
: 20250000755 |
Date |
: 10/06/2026 |
| Patient Name |
: Hemen Deka |
Age & Gender |
: 61 Yrs. / Male |
| Contact No. |
: 9365730577 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (29/Sep/2010) | ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (29/Sep/2010) | ANEMIA (29/Sep/2025) | A2G3 DKD (29/Sep/2025) | |
|
Subjective |
: |
TYPE 2 DM FOR 15 YEARS,ASCVD FOR 15 YEARS,DKD,HAS STOPPED DULAGLUTIDE |
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,ATHEROSCLEROTIC CARDIOVASCULAR DISEASE,MALENA,A2G3 DKD |
|
Plan |
: |
CONTINUE CURRENT MEDICATIONS,SEE ME IN 2 MONTHS WITH TESTING |
|
| Salient Investigations |
: |
CREATININE: 1.68 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 44.47 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 105 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.90 % | POST PRANDIAL GLUCOSE (2HPP): 154 mg/dL | UREA: 35 mg/dL | POTASSIUM: 4.8 meQ/L | FERRITIN: 109 | HEMOGLOBIN: 11.5 g/dL | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES |
SQ |
12-0-8 UNITS |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
2 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
3 |
IN TRULICITY 1.5 MG
DULAGLUTIDE 1.5 MG |
|
ONCE A WEEK |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 09/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP BUN CR |
| |
|
| |
|
|
